{
	"section-title": "story of the week",
	"section-id": "story-of-the-week",
	"section-description": "Opinions and insights from key opinion leaders and the front lines of care.",
	"items": [
		{
			"id": "0001",
			"featured": true,
			"type": "Journal Scan: Research",
			"section": "Story of the week",
			"pub-date": {
				"date": {
					"year": "2012", "month": "March", "day": "19"},
				"time":{
					"hour": "2012", "minute": "March"}
			},
			"practice-relevance" : 3,
			"title": "New Induction Standard for Acute Myeloid Leukemia",
			"url": "",
			"source": {
				"type": "expert",
				"name": {
					"firstName": "Lee", "middleName": "S.", "lastName": "Schwartzberg", "honorific": "MD, FACP"},
				"position": {
				"title":"placeholder"},
				"photo": {
					"url":"content/img/users/Bonnie_Cunningham_2009_REVI_tcm8-199718.jpg"}
			},
			"item-content": {
				"take-home-message": "<p>In a phase III trial of patients with acute myeloid leukemia, adding cladribine, but not fludarabine, to induction with daunorubicin/cytarabine significantly increased overall survival and can be considered a new standard of care.</p>",
				"referenced-item": {
					"featured": true,
					"type": "commentary",
					"section": "commentary",
					"title": "Cladribine, But Not Fludarabine, Added to Daunorubicin and Cytarabine During Induction Prolongs Survival of Patients With Acute Myeloid Leukemia: A Multicenter, Randomized Phase III Study",
					"source": {
						"type": "journal",
						"journal":{
							"title": "Journal of Clinical Oncology",
							"url": "",
							"img": "content/img/journal/jco.gif",
							"pub-date": {
								"date": {
									"year": "2012", "month": "March", "day": "19"}
								}
							}
						}
					}
				}
		}
	]
}
